Myonexus Therapeutics: 0 to >$200 Million in Less than Three Years
Innovate New Albany 8000 Walton Parkway Suite 200, New Albany, OH, United StatesDr. Triplett will share the story of how Myonexus Therapeutics was formed and quickly achieved a $200+ million exit in less than three years. Attendees will learn about Columbus' life sciences innovation strengths and how the Columbus Region can build upon Myonexus and other successes to create a sustainable, larger life sciences venture and innovation ecosystem. Dr. Michael Triplett is a co-founder and Managing Member of 1787 Bio, LLC, a life sciences investment organization based
Read More